SCHEMBL29955976

SCHEMBL29955976

COc1ccc(C=O)c(C(=O)O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.61
TYR P14679 1/20 0.61
TRIM33 Q9UPN9 1/20 0.61
ALDH1A1 P00352 5/20 0.58
ERN1 O75460 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
KDM4E B2RXH2 5/20 0.54
POLB P06746 4/20 0.54
LMNA P02545 2/20 0.54
HPGD P15428 1/20 0.54
HSD17B10 Q99714 1/20 0.54
AKR1C3 P42330 4/20 0.48
AKR1C2 P52895 4/20 0.48
MEN1 O00255 2/20 0.47
MAPT P10636 2/20 0.47
KMT2A Q03164 2/20 0.47
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
SLC16A3 O15427 1/20 0.45
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL548189 1.00 TRIM24 (0.61) TRIM24TYRTRIM33ALDH1A1ERN1
SCHEMBL13329535 0.86 TRIM24 (0.61) TRIM24TYRTRIM33ALDH1A1ERN1
SCHEMBL4733806 0.86 ERN1 (0.61) TRIM24TYRTRIM33ALDH1A1ERN1
SCHEMBL4476198 0.84 TRIM24 (0.59) TRIM24TYRTRIM33ALDH1A1ERN1
SCHEMBL12837795 0.84 SMN1; SMN2 (0.54) TRIM24TYRTRIM33ALDH1A1SMN1; SMN2
SCHEMBL7302719 0.84 TRIM24 (0.59) TRIM24TYRTRIM33ALDH1A1ERN1
SCHEMBL10457145 0.83 KDM4E (0.58) ALDH1A1SMN1; SMN2KDM4ELMNAHPGD
SCHEMBL7235657 0.82 ALDH1A1 (0.61) TRIM24TYRTRIM33ALDH1A1ERN1
SCHEMBL29956204 0.81 TRIM24 (0.56) TRIM24TYRTRIM33ALDH1A1ERN1
SCHEMBL11530087 0.81 TRIM24 (0.56) TRIM24TYRTRIM33ALDH1A1ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118580205-A Use of PSF-LncRNA interaction inhibitor in preparation of medicine for treating cancer 山东铂源药业股份有限公司 2024-09-03 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed